Latest news

Thumbnail image for Final NICE green light for Pfizer’s Mylotarg

Final NICE green light for Pfizer’s Mylotarg

Cost regulators for the NHS in England and Wales have now published final guidelines recommending Mylotarg, alongside daunorubicin and cytarabine, as an option for untreated de novo CD33-positive acute myeloid leukaemia (AML).

15th November 2018

Thumbnail image for Lilly files lasmiditan for migraine

Lilly files lasmiditan for migraine

Eli Lilly has filed an application in the US to market lasmiditan for the acute treatment of migraine with or without aura in adults.

15th November 2018

Previous  --   2 3 4 5 6 7 8 9 10 11   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download